Global Norovirus Vaccines in Pipeline Forecast 2020-2030Takeda, Vaxart, Cocrystal Pharma, PanTheryx, Calici TherapeuticsLONDON, Jan. 28, 2020 /PRNewswire/ -- The global norovirus vaccines market is estimated to grow at a CAGR of 7.6% during the forecast period. In 2022, North America is expected to hold a market share of 61% of the global norovirus vaccines market. The Visiongain report provides clear detailed insight into the global norovirus vaccines in pipeline forecast. • What are the main trends that will affect the world norovirus vaccines market between 2020 and 2030? • How will the global norovirus vaccines market evolve over the forecasted period, 2020 to 2030?

Source: The North Africa Journal January 28, 2020 09:56 UTC